A synthetic peptide from AA 50-100 of human VAMPB conjugated to an immunogenic carrier protein was used as the antigen. The peptide is homologous in many species including human, rat, mouse, zebra fish, bovine, xenopus and chicken.
Isotyp
IgG
Applikationshinweise
IHC, WB. A concentration of 10-50 μg,ml of is recommended. The optimal concentration should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstitute in 500 μL of sterile water. Centrifuge to remove any insoluble material.
Handhabung
Avoid freeze and thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Haltbarkeit
12 months
Target
VAMP A/B
Hintergrund
FUNCTION: May play a role in vesicle trafficking. SUBUNIT: Homodimer, and heterodimer with VAPA. Interacts with VAMP1 and VAMP2. SUBCELLULAR LOCATION: Cell membrane, Single-pass type IV membrane protein. Intracytoplasmic membrane, Single-pass type IV membrane protein. Note: Present in the plasma membrane and in intracellular vesicles. TISSUE SPECIFICITY: Ubiquitous. Isoform 1 predominates.,Vesicle Transport,VAMP-associated protein B, VAMP-B, VAP-B, Vesicle-associated membrane protein-associated protein B/C, VAMP-associated protein B/C, VAMP-B/VAMP-C, VAP-B/VAP-C, VAPB, VAMP A